Lifestyle therapy plus lisdexamfetamine for Pediatric Obesity
Phase-Based Progress Estimates
Effectiveness
Safety
University of Minnesota, Minneapolis, MN
Pediatric Obesity+2 More
Lisdexamfetamine Dimesylate - DrugEligibility
< 18
All Sexes
What conditions do you have?
Select
Eligibility
< 18
All Sexes
What conditions do you have?
Select
Study Summary
This study will randomize children who have difficulty maintaining a healthy weight to one of two treatment groups: lifestyle therapy plus lisdexamfetamine or lifestyle therapy plus placebo.
Eligible Conditions
- Pediatric Obesity
- Obesity
Treatment Effectiveness
Effectiveness Progress
Other trials for Pediatric Obesity
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 24 weeks
24 weeks
Percent change in Body Mass Index
Trial Safety
Safety Progress
Other trials for Pediatric Obesity
Trial Design
2 Treatment Groups
Lifestyle therapy plus lisdexamfetamine
1 of 2
Lifestyle therapy plus placebo
1 of 2
Active Control
Non-Treatment Group
40 Total Participants · 2 Treatment Groups
Primary Treatment: Lifestyle therapy plus lisdexamfetamine · Has Placebo Group · Phase < 1
Lifestyle therapy plus lisdexamfetamine
Drug
ActiveComparator Group · 1 Intervention: Lisdexamfetamine Dimesylate · Intervention Types: DrugLifestyle therapy plus placebo
Behavioral
PlaceboComparator Group · 1 Intervention: Lifestyle therapy · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks
Closest Location: University of Minnesota · Minneapolis, MN
1993First Recorded Clinical Trial
11 TrialsResearching Pediatric Obesity
830 CompletedClinical Trials
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,227 Previous Clinical Trials
1,454,363 Total Patients Enrolled
27 Trials studying Pediatric Obesity
4,934 Patients Enrolled for Pediatric Obesity
Eligibility Criteria
Age < 18 · All Participants · 4 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have a body mass index (BMI) of at least 1.2 times the 95th percentile.
You have a prior failed attempt of lifestyle therapy.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments